Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
about
Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ miceInterleukin-32 promotes osteoclast differentiation but not osteoclast activationRole of RANKL inhibition in osteoporosisBiology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritisIL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor bindingT lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signalingBone and brain metastasis in lung cancer: recent advances in therapeutic strategiesControl of RANKL gene expressionActivated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLThe role of RANK-ligand inhibition in cancer: the story of denosumabOsteoimmunology: interactions of the bone and immune systemOsteoclasts: what do they do and how do they do it?Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infectionAn Increased Risk of Osteoporosis during Acquired Immunodeficiency SyndromeCytokine, activation marker, and chemokine receptor expression by individual CD4(+) memory T cells in rheumatoid arthritis synoviumExposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationIL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritisThe role of osteoprotegerin in arthritisEnhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesisHormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1Bone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destructionBone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritisThe molecular mechanism of osteoclastogenesis in rheumatoid arthritisMechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivoRANK-RANKL signalling in cancerBone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T CellsElevated serum osteoprotegerin levels in women: friend or foe?Osteoimmune Interactions in Inflammatory Bowel Disease: Central Role of Bone Marrow Th17 TNFα Cells in OsteoclastogenesisThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisAnimal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewGlucocorticoid-induced osteoporosisPaget's disease of bone: an osteoimmunological disorder?Host response mechanisms in periodontal diseasesOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsNuclear receptors in bone physiology and diseases
P2860
Q21091051-7270784A-F6BB-454D-A5C4-B5D57C7F70DFQ21092154-BF061EBA-CC61-4FCD-8BDF-5E863C27B6F4Q21195417-ED09026B-97D1-4224-BE81-66477CAFD6F1Q21195672-3327D915-7447-4249-A3D4-751B0CCE0F5EQ24291729-402C15E5-23BE-4A5D-B791-852764477EC8Q24311640-484C9C4B-D0DF-4EED-81A4-BE8E30C9C44FQ24568071-6885C355-5AE1-4FE1-9E7E-338152E9FAC4Q24619669-82DFC7B6-9714-41E1-A9C8-9C767ADE155DQ24632345-12FAE37C-D8AE-417A-A873-1639A28B3C10Q24633284-F3758DA3-1528-4F55-B3A6-5B15254010E2Q24655113-C51F9B64-3961-41B7-B99C-91F5E6F69C99Q24683898-31CE3755-F682-4C12-8F34-8DC74CE8F8A9Q24701763-A4E3AE2C-C7A5-48E6-A122-83C35185A80CQ24791238-9A84E72B-EC23-47E2-BC26-AF23DC8FD700Q24792676-30193020-B6F1-400B-9705-A39987F08C35Q24796088-CC00DCD2-154B-433D-ACD0-C01E16C7492AQ24796707-539D9521-E702-4B88-B2F2-316A9FD42E18Q24797889-CB717048-CD30-4F92-8777-BE0F1C4C02F9Q24800726-F20AD38D-ED7C-4F48-ACFD-9965123E96C1Q24804802-8B2EC3C1-5D64-4D62-BE7D-982F697D4A0EQ24805142-F0E0E0FD-2B5F-4E98-88F4-4B77F35F2811Q24805207-63420481-8EDA-4DA3-B589-4219ADDD13D2Q24805487-463AA335-5A18-4125-AFF6-D1844F78351AQ24805600-A78B1B7F-467F-4732-82E1-3ADF04E803B4Q24806322-BF98F251-66DA-4C8F-8220-CBBD6CD04FADQ24806684-DEAA1E8D-A4E8-40F6-B71B-81DBF49D7399Q24806847-A9CF74F9-E71C-4320-AFEB-056232FD10B3Q24812326-B06CD587-DA99-456A-BB04-BFFCDEB50F7FQ24812465-C7D7C4FE-A190-46D4-8FA9-97B1D64A5216Q26747442-4ADCEEB0-01CD-4A6B-ABE5-5476CCDB9198Q26766714-239BD2B3-375D-4E1A-9189-750368B42412Q26769686-89F7698B-AEBB-4A63-9B52-3396100DF086Q26770666-0B890FEA-82D4-4044-B4A0-E2C0EBB6B9DDQ26773017-714BDC50-18B0-4C50-BBA2-5B1D1A007001Q26774874-38219280-A3A0-459B-88A7-46D1E17EA620Q26778272-848D8F64-6948-41C7-A0A3-261A2351436BQ26796458-6D12FC22-5CA5-4B13-B5E2-1C974A0DC1C4Q26801846-15305B38-D595-4AE2-B00B-6CAC515316C1Q26828486-AEA6605E-971A-4864-9A62-BD1EBC9D3A3DQ26853017-1ED2F654-5524-4515-B57A-322E793006C5
P2860
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Activated T cells regulate bon ...... through osteoprotegerin ligand
@ast
Activated T cells regulate bon ...... through osteoprotegerin ligand
@en
type
label
Activated T cells regulate bon ...... through osteoprotegerin ligand
@ast
Activated T cells regulate bon ...... through osteoprotegerin ligand
@en
prefLabel
Activated T cells regulate bon ...... through osteoprotegerin ligand
@ast
Activated T cells regulate bon ...... through osteoprotegerin ligand
@en
P2093
P3181
P356
P1433
P1476
Activated T cells regulate bon ...... through osteoprotegerin ligand
@en
P2093
Campagnuolo G
Capparelli C
P2888
P304
P3181
P356
10.1038/46303
P407
P577
1999-11-01T00:00:00Z
P6179
1028279868